 |
|
|
| |
Distinct evolutionary pathways of NS5A inhibitor resistance in patients with genotype 1a versus 1b infection during monotherapy with MK-8742 (Elbasvir)
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Sara Williford, M.D., Shuntai Zhou, M.D., Christina Burch, Ph.D., Ernest Asante-Appiah, Ph.D., Anita Howe, Ph.D., Ronald Swanstrom, Ph.D., Stanley M. Lemon, M.D.
University of North Carolina at Chapel Hill Merck Research Laboratories
|
| |
|
|
|
|
|
